Catalent Agrees to Acquire Pearl Combining Leaders in Gene Therapy & Complex Biologics Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Integrated Fill/Finish Solutions Your trusted partner for clinical and commercial fill finish and final product supply Learn More Comprehensive Biomanufacturing Solutions Your trusted partner for flexible clinical and commercial biomanufacturing Learn More Proven Technologies Create next generation therapies leveraging our suite of proprietary technology platforms Learn More Catalent Agrees to Acquire Pearl Combining Leaders in Gene Therapy & Complex Biologics Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Integrated Fill/Finish Solutions Your trusted partner for clinical and commercial fill finish and final product supply Learn More Comprehensive Biomanufacturing Solutions Your trusted partner for flexible clinical and commercial biomanufacturing Learn More Proven Technologies Create next generation therapies leveraging our suite of proprietary technology platforms Learn More How can we work together BiologicsDevelopment Drug SubstanceBiomanufacturing Drug ProductFill / Finish Clinical SupplyServices Latest News Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC Technology WEBINAR: CONTINUOUS PROCESSING IN BIOMANUFACTURING There are many factors to consider when determining whether to adopt continuous processing. This webinar discusses a study comparing continuous and batch processing and challenges of adopting. Analytical Comprehensive integrated and standalone bioanalytical services for drug substance, drug product and intermediates, both new biologic entities and biosimilars/biobetters. Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. See all of our locations NEWS Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion Triphase Initiates Phase 1 Clinical Trial of B-cell Lymphoma Treatment Catalent Biologics to Present on Tech Transfer, Biomanufacturing and Aseptic Processing at INTERPHEX Advances in Biologics Development to be Discussed at Symposium Hosted by the Catalent Applied Drug Delivery Institute at the UCSF Mission Bay Campus EVENTS PEGS Webinar | How To Get The Most Out Of Your Phase I Biologic Study CPhI North America CASSS Bioassays Symposium EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays
